S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 2, 2001, Pages 581-591

  Millan, Mark J ^a   Dekeyne, Anne ^a   Papp, Mariusz ^b   Drieu La Rochelle, Christophe ^c   Macsweeny, Cliona ^c   Peglion, Jean Louis ^a   Brocco, Mauricette ^a  

^a INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c Biotrial SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; CHLORAMPHETAMINE; CITALOPRAM; CLOMIPRAMINE; NORADRENALIN TRANSPORTER; REBOXETINE; S 18616; S 33005; SEROTONIN TRANSPORTER; SUCROSE; UNCLASSIFIED DRUG; VENLAFAXINE;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG POTENCY; FORCED SWIMMING TEST; HYPOTHERMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; TAIL FLICK TEST;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CARRIER PROTEINS; CITALOPRAM; CLOMIPRAMINE; CYCLOHEXANOLS; DISCRIMINATION (PSYCHOLOGY); MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MORPHOLINES; MUSCULOSKELETAL EQUILIBRIUM; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; P-CHLOROAMPHETAMINE; RATS; RATS, WISTAR; REACTION TIME; RESERPINE; SEROTONIN AGENTS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS;

EID: 0034925001     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites
2. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. In vivo electrophysiological studies in the rat
3. 1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat
4. Benzodiazepine and serotonergic modulation of antipredator and conspecific defense
5. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders
6. Is the forced swimming test a suitable model for revealing antidepressant activity ?
7. Motor and cognitive aspects of motor retardation in depression
8. Aggressive behaviour and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
9. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat
10. Effect of subchronic antidepressant treatments on behavioural, neurochemical, and endocrine changes in the forced-swim test
11. Reboxetine, a selective norepinephrine reuptake inhibitor, alters active behaviours in a modified rat forced swim test
12. Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in rats
13. Serotonin, social status and aggression
14. The pharmacology of impulsive behaviour in rats. V: The effects of drugs on responding under a discrimination task using unreliable visual stimuli
15. Antidepressants
16. Fluoxetine, a selective inhibitor of serotonin uptake
17. Evidence of the dual mechanisms of action of venlafaxine
18. 2-Adrenoceptor agonists and anaesthesia
19. Reversal of helpless behaviour by serotonin uptake blockers in rats
20. Noradrenergic denervation attenuates desipramine enhancement of aggressive behavior in isolated mice
21. Neurobiological mechanisms controlling aggression: Preclinical developments for pharmacotherapeutic interventions
22. Citalopram elicits a discriminative stimulus in rats at a dose selectively increasing extracellular levels of serotonin vs dopamine and noradrenaline
23. Reciprocal autoreceptor and heteroreceptor control of serotonergic dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents
24. 2-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine
25. 2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity
26. The adverse effects of antidepressants
27. Chronic treatment with clomipramine and mianserin increases the hierarchical position of subdominant rats housed in triads
28. Biochemical, neurophysiological and behavioural effects of WAY-45,233 and other identified metabolites of the antidepressant venlafaxine
29. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice: A putative test for anxiolytic agents
30. 2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine
31. Biochemical and pharmacological tests for the prediction of ability of monoamine uptake blockers to inhibit the uptake of noradrenaline in vivo: The effects of desipramine, maprotiline, femoxetine and citalopram
32. Efficacy of drug treatment in obsessive-compulsive disorder
33. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder
34. Preclinical pharmacology of citalopram
35. Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers
36. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity
37. Antidepressant behavioural effects by dual inhibition of monoamine reuptake in the rat forced swimming test
38. Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies
39. Behavioural profiles of SSRIs in animal models of depression, anxiety and aggression
40. Venlafaxine, a novel antidepressant compound
41. The automated tail suspension test: A computerized device which differentiates psychotropic drugs
42. Anti-immobility activity of different antidepressant drugs using the tail suspension test in normal or reserpinized mice
43. Animal behavioural studies in the evaluation of antidepressant drugs
44. Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder
45. Interactions between clonidine and antidepressant drugs: A method for identifying antidepressant-like agents
46. Effects of antidepressant drugs on rats bred for low activity in the swim test
47. Effects of serotonergic agents on isolation-induced aggression
48. Animal models as simulations of depression
49. Validity, reliability and utility of the chronic mild stress model of depression: A 10-year review and evaluation
50. Reboxetine a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor